Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa.

dc.contributor.affiliationNewlands Clinic, Harare, Zimbabwe.
dc.contributor.affiliationLighthouse Trust Clinic, Lilongwe, Malawi.
dc.contributor.affiliationEmpilweni Services and Research Unit, Department of Paediatrics & Child Health, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
dc.contributor.affiliationMRC Clinical Trials Unit at UCL, University College London (UCL), London, United Kingdom.
dc.contributor.affiliationDivision of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
dc.contributor.affiliationTREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
dc.contributor.affiliationSolidarMed, Luzern, Switzerland.
dc.contributor.affiliationDepartment of Paediatrics and Child Health, Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa.
dc.contributor.affiliationHarriet Shezi Children's Clinic, Wits Reproductive Health and HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.
dc.contributor.affiliationMédecins Sans Frontiers, Khayelitsha, South Africa.
dc.contributor.affiliationKheth'Impilo, Cape Town, South Africa.
dc.contributor.affiliationDepartment of Global Health and Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
dc.contributor.affiliationHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
dc.contributor.affiliationCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorTsondai PR
dc.contributor.authorSohn AH
dc.contributor.authorPhiri S
dc.contributor.authorSikombe K
dc.contributor.authorSawry S
dc.contributor.authorChimbetete C
dc.contributor.authorFatti G
dc.contributor.authorHobbins MA
dc.contributor.authorTechnau KG
dc.contributor.authorRabie H
dc.contributor.authorBernheimer J
dc.contributor.authorFox MP
dc.contributor.authorJudd A
dc.contributor.authorCollins IJ
dc.contributor.authorDavies MA
dc.date.accessioned2025-05-23T11:41:13Z
dc.date.issued2020-Jan
dc.description.abstractINTRODUCTION: As adolescents and young people living with HIV (AYLH) age, they face a "transition cascade," a series of steps associated with transitions in their care as they become responsible for their own healthcare. In high-income countries, this usually includes transfer from predominantly paediatric/adolescent to adult clinics. In sub-Saharan Africa, paediatric HIV care is mostly provided in decentralized, non-specialist primary care clinics, where "transition" may not necessarily include transfer of care but entails becoming more autonomous for one's HIV care. Using different age thresholds as proxies for when "transition" to autonomy might occur, we evaluated pre- and post-transition outcomes among AYLH. METHODS: We included AYLH aged <16 years at enrolment, receiving antiretroviral therapy (ART) within International epidemiology Databases to Evaluate AIDS Southern Africa (IeDEA-SA) sites (2004 to 2017) with no history of transferring care. Using the ages of 16, 18, 20 and 22 years as proxies for "transition to autonomy," we compared the outcomes: no gap in care (≥2 clinic visits) and viral suppression (HIV-RNA <400 copies/mL) in the 12 months before and after each age threshold. Using log-binomial regression, we examined factors associated with no gap in care (retention) in the 12 months post-transition. RESULTS: A total of 5516 AYLH from 16 sites were included at "transition" age 16 (transition-16y), 3864 at 18 (transition-18y), 1463 at 20 (transition-20y) and 440 at 22 years (transition-22y). At transition-18y, in the 12 months pre- and post-transition, 83% versus 74% of AYLH had no gap in care (difference 9.3 (95% confidence interval (CI) 7.8 to 10.9)); while 65% versus 62% were virally suppressed (difference 2.7 (-1.0 to 6.5%)). The strongest predictor of being retained post-transition was having no gap in the preceding year, across all transition age thresholds (transition-16y: adjusted risk ratio (aRR) 1.72; 95% CI (1.60 to 1.86); transition-18y: aRR 1.76 (1.61 to 1.92); transition-20y: aRR 1.75 (1.53 to 2.01); transition-22y: aRR 1.47; (1.21 to 1.78)). CONCLUSIONS: AYLH with gaps in care need targeted support to prevent non-retention as they take on greater responsibility for their healthcare. Interventions to increase virologic suppression rates are necessary for all AYLH ageing to adulthood.
dc.identifier.doi10.1002/jia2.25447
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10431
dc.sourceJournal of the International AIDS Society
dc.titleCharacterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa.

Files

Collections